PI3K/AKT/mTOR通路
自噬
癌症
癌细胞
蛋白激酶B
药理学
细胞凋亡
癌症研究
生物
医学
生物化学
内科学
作者
Prasath Manogaran,Narasimha M. Beeraka,Raja Singh Paulraj,Perumal Sathiyachandran,Mahadevaswamy Thammaiappa
标识
DOI:10.2174/1568026623666230111154537
摘要
Abstract: The adverse toxicities and stemness are two major factors that constrained the usage of therapeutic strategies to target several cancer types. Previous studies explored the efficacy of PI3K/mTOR inhibitors, pan-PI3K inhibitors, and isoform-specific inhibitors against several cancer types, and many of them are currently in clinical trials. The current review described the efficacy of alkaloids derived from dietary plant sources in developing a new anti-cancer to reduce the preva-lence of cancer through the modulation of apoptosis, autophagy, and ferroptosis. We have substan-tially collected the information pertinent to several intracellular pathways, including PI3K signaling, apoptosis, ferroptosis, and autophagy in modulating cancer progression mediated by the plant-derived alkaloids such as daurisoline, dauricine, vasicine, vasicinone, 2-Acetyl-benzylamine, nu-ciferine, liensinine, gramine, and berbamine. These alkaloids exhibit significant anti-cancer poten-tial to inhibit cancer cells by enhancing the intracellular ROS level and modulation of several sig-naling pathways, mainly through the PI3K/AKT pathway. These alkaloids can modulate chemo-therapeutic agents' efficacy in various cancer cells, both in vitro and in vivo models. Overall the fu-tures for the continued use of alkaloids from natural sources against cancer have to be extended, with the implementation of significant enhancements in the chemistry of these alkaloids for targeted delivery. In this review, we have selected major bioactive alkaloids of dietary and medicinal plants origin and discussed the anti-cancer and combinatorial therapeutic implications of these compounds with several FDA-approved drugs against various cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI